G. W. Gokel et al.
1
12-Bromo-N,N-bis(2-(trimethylsilyloxy)ethyl)dodecanamide (I): A solu-
tion of 12-bromododecanoic acid (1.84 g, 6.59 mmol), protected dietha-
nolamine A (2.00 g, 6.59 mmol), EDCI (1.50 g, 7.82 mmol) and DMAP
(cat.) in dry CH2Cl2 (30 mL) was stirred at RT overnight. The reaction
was washed with 5% aq. citric acid (2ꢃ20 mL) and brine (20 mL). The
organic phase was dried (MgSO4) and the solvent was evaporated (in
solid (0.20 g, 85%). M.p. 191–1938C; H NMR: d = 0.031–0.067 (d, 12H,
J=11 Hz), 0.88–0.89 (d, 18H, J=5 Hz), 3.54 (t, 2H, J=5 Hz), 3.66 (t,
2H, J=5 Hz), 3.79 (m, 4H), 4.37 (s, 4H), 4.87 (s, 2H), 6.82–6.84 (d, 2H,
J=8 Hz), 6.97–7.01 (m, 6H), 7.35–7.48 ppm (m, 8H); 13C NMR (CDCl3 +
CD3OD): d = ꢀ5.4, 18.4, 26.0, 48.9, 51.0, 61.2, 61.6, 66.9, 97.3, 115.2,
115.7, 127.8, 127.7, 134.0, 134.4, 157.5, 157.8, 158.0, 169.0 ppm.
1
vacuo) to afford target product as viscous oil (3.24 g, 89%). H NMR: d
Protected
3 (N): Compound M (0.19 g, 0.25 mmol), C (0.032 g,
= 0.0058–0.0616 (s, 12H), 0.84–0.89 (s, 8H), 1.22–1.24 (m, 14H), 1.57 (m,
2H), 1.81 (m, 2H), 2.33 (t, 2H, J=7.5 Hz), 3.35–3.50 (m, 6H), 3.65–
3.71 ppm (m, 4H); 13C NMR: d = ꢀ5.2, 18.5, 25.6, 26.1, 26.1, 28.4, 29.0,
29.7, 29.9, 33.1, 33.5, 34.3, 49.0, 51.6, 61.4, 61.9, 174.0 ppm.
0.12 mmol), Na2CO3 (0.30 g, 2.8 mmol), and KI (cat.) were suspended in
butyronitrile (20 mL). The mixture was stirred and heated under reflux
for 3 d, cooled, filtered, and concentrated under vacuum. The residue
was washed with hot MeOH/CHCl3 to give the target compound as a
brown powder (0.10 g, 45%). M.p. 158–1628C; 1H NMR: d = ꢀ0.040–
0.013 (d, 24H, J=8 Hz), 0.80–0.82 (d, 36H, J=3 Hz), 3.46 (t, 4H, J=
5 Hz), 3.57 (t, 4H, J=5 Hz), 3.69–3.73 (m, 8H), 4.31 (s, 8H), 4.58 (s,
4H), 4.76 (s, 4H), 6.91–7.0 (m, 16H), 7.28–7.48 (m, 19H), 7.89 (s, 1H),
8.30 ppm (s, 2H); 13C NMR: d = ꢀ5.3, 18.4, 26.1, 29.9, 48.9, 51.0, 61.4,
61.7, 66.9, 67.6, 68.1, 111.8, 115.3, 115.3, 115.4, 116.6, 128.0, 128.0, 128.1,
128.4, 130.0, 134.2, 137.8, 156.3, 157.7, 158.0, 158.3, 166.6, 168.6 ppm; MS-
FAB : m/z: calcd for: 1753.8457, found: 1753.8483 [M+Na]+.
12-(4’-Hydroxybiphenyl-4-yloxy)-N,N-bis(2-(trimethylsilyloxy)ethyl)-do-
decanamide (J): A mixture of compound I (1.00 g, 1.82 mmol), 4,4’-bi-
phenol (0.35 g, 1.9 mmol), Na2CO3 (2.00 g, 18.8 mmol), KI (cat.) in butyr-
onitrile (20 mL) was heated to reflux overnight. The reaction system was
cooled, filtered and the solvent was evaporated (in vacuo) to afford
crude product as dark oil. The crude product was chromatographed
(SiO2, CHCl3/MeOH 98:2) to afford J as a light yellow oil (0.38 g, 30%).
1H NMR: d = 0.00–0.048 (s, 12H), 0.84 (s, 18H), 1.24 (m, 18H), 2.40 (t,
2H, J=7.5 Hz), 3.44–3.50 (m, 4H), 3.68–3.72 (m, 4H), 3.92 (t, 2H, J=
6 Hz), 6.85–9.91 (m, 4H), 7.35–7.42 ppm (m, 4H); 13C NMR: d = ꢀ5.2,
18.4, 25.6, 26.1, 29.7, 33.5, 49.1, 51.7, 61.4, 61.9, 68.3, 115.0, 115.9, 127.9,
128.1, 133659, 155.3, 158.5, 174.0 ppm.
Aplosspan 3: To a solution of I (20 mg, 0.012 mmol) in THF (3.0 mL), a
solution of Bu4NF (30 mg, 0.12 mmol) in THF (3 mL) was added drop-
wise at RT. The mixture was stirred at RT for 2.5 h. Water (3 mL) was
added to quench the reaction. The solid was collected, washed with
CHCl3, acetone, and water to afford 3 (9.73 mg, 66%). M.p. >2008C;
1H NMR ([D6]DMSO, 508C): d = 3.43–3.62 (m, 16H), 4.39 (s, 8H), 4.50
(brs, 2H), 4.73 (s, 4H), 4.80 (brs, 2H), 4.892 (s, 4H), 6.98–7.10 (m, 16H),
7.27 (t, 1H, J=8 Hz), 7.38–7.39 (m, 2H), 7.50–7.58 (m, 16H), 8.02 (s,
1H), 9.95 ppm (s, 2H).
Protected
2 (K): Compound J (0.26 g, 0.37 mmol), central unit E
(0.040 g, 0.15 mmol), Na2CO3 (0.40 g, 3.7 mmol), and KI (cat.) in butyro-
nitrile (20 mL) were heated to reflux for 3 d. The reaction system was
cooled, filtered and the solvent was evaporated (in vacuo) to afford
crude product. The crude product was recrystallized from CH3Cl/MeOH
to give protected 2 (K) as a light yellow powder (25 mg, 10%). M.p. 92–
968C; 1H NMR: d = 0.036–0.045 (m, 24H), 0.88 (s, 36H), 1.25–1.79 (m,
36H), 2.37 (t, 4H, J=7.5Hz), 3.46–3.52 (m, 8H), 3.69–3.75 (m, 8H), 3.98
(t, 4H, J=6 Hz), 4.64 (s, 4H), 6.94–7.06 (m, 8H), 7.45–7.54 (m, 11H),
8.01 (s, 1H), 8.38 ppm (s, 2H); 13C NMR: d = ꢀ5.3, ꢀ5.2, 14.3, 18.4,
18.4, 22.9, 25.6, 26.1, 26.1, 26.3, 29.5, 29.6, 29.7, 29.8, 29.9, 32.1, 33.5, 49.0,
51.6, 61.4, 61.9, 68.0, 68.3, 111.8, 115.1, 115.4, 116.6, 127.8, 128.0, 128.3,
130.0, 132.9, 135.7, 137.8, 156.2, 158.8, 166.6, 173.8 ppm; MS-FAB: m/z:
calcd for: 1609.9912; found: 1609.9894 [M+Na]+.
Preparation of hydraphile 4:
A mixture of N-benzyl-4,13-diaza-
[18]crown-6 (0.12 g, 0.34 mmol), N,N’-(1,3-phenylene)-bis(12-bromodode-
canamide) (G; 0.10 g, 0.16 mmol, see preparation above for 1), Na2CO3
(0.50 g, 4.7 mmol), and KI (cat.) in butyronitrile (30 mL) was heated to
reflux for 24 h. The reaction mixture was cooled, filtered and the solvent
was evaporated (in vacuo). The residue was chromatographed (SiO2,
EtOAc/Et3N 10:1) to afford the product as an oil (23 mg, 13%).
1H NMR: d
= 1.17–1.43 (m, 32H), 1.66–1.68 (m, 4H), 2.27–2.34 (m,
4H), 2.47–2.52 (m, 4H), 2.76–2.82 (m, 16H), 3.56–3.64 (m, 36H), 7.20–
7.34 (m, 13H), 7.79 ppm (m, 1H); 13C NMR: d = 25.9, 27.1, 27.6, 29.4,
29.5, 29.6, 29.7, 38.0, 54.1, 54.2, 56.0, 60.1, 69.9, 70.2, 70.9, 115.4, 127.1,
128.4, 129.1, 129.7, 138.9, 139.8, 171.9 ppm; MS-FAB: m/z: calcd for:
1195.8338, found: 1195.8344 [M+Na]+.
Aplosspan 2: Concentrated HCl (37.4%, 0.5 mL) was added dropwise in
a solution of K (30 mg, 0.019 mmol) in EtOH (5 mL). The reaction was
stirred at RT for 2 h. The target product (12 mg, 56%) precipitated from
1
the reaction system. M.p >2458C (decomp); H NMR ([D6]DMSO): d =
1.34–1.49 (m, 32H), 1.77–1.79 (m, 4H), 2.40–2.42 (m, 4H), 3.09–3.74 (m,
overlap with solvent peak), 4.03–4.07 (t, 4H, J=6 Hz), 4.34 (m, 2H), 4.78
(s, 4H), 7.02–7.13 (m, 8H), 7.34–7.64 (m, 13H), 8.13 (s, 1H), 10.27 ppm
(s, 2H); 13C NMR: d = 24.2, 24.9, 25.5, 28.5, 28.8, 29.0, 32.2, 33.2, 45.5,
49.1, 56.2, 59.1, 59.3, 67.2, 67.4, 114.5, 115.0, 127.2, 127.3, 128.9, 132.0,
133.0, 138.7, 156.9, 157.8, 166.6, 172.4, 172.7 ppm.
Preparation of hydraphile 5: Compound 5 was reported in previous stud-
ies.[24]
Preparation of aplosspan 3
Acknowledgements
N,N-Bis(2-(tert-butyldimethylsilyloxy)ethyl)-2-(4’-hydroxybiphenyl-4-
yloxy)acetamide (F) was prepared as described above.
We thank the NIH (GM-36262, GM-63190) and NSF (CHE-0415586) for
grants that supported this work.
2-(4’-(2-(4’-(Benzyloxy)biphenyl-4-yloxy)ethoxy)biphenyl-4-yloxy)-N,N-
bis(2-(tert-butyldimethylsilyloxy)ethyl)acetamide (L):
A mixture of F
(0.27 g, 0.70 mmol), D (0.26 g, 0.46 mmol), Na2CO3 (1.00 g, 9.43 mmol)
and KI (cat.) in butyronitrile (20 mL) was stirred under reflux for 4 d.
The mixture was cooled, filtered, the solvent was evaporated, and the re-
sulting solid was recrystallized from MeOH/CHCl3 to afford L as a white
[1] a) G. M. Preston, T. P. Carroll, W. B. Guggino, P. Agre, Science 1992,
256, 385–387; b) R. MacKinnon, S. L. Cohen, A. Kuo, A. Lee, B. T.
Dutzler, E. B. Campbell, M. Cadene, B. T. Chait, R. MacKinnon,
1
solid (0.13 g, 50%). M.p. 155–1578C; H NMR: d = 0.039–0.066 (d, 12H,
J=8 Hz), 0.88–0.89 (d, 18H, J=3 Hz), 3.54 (m, 2H), 3.65 (m, 2H), 3.78–
3.80 (m, 4H), 4.39 (s, 4H), 4.84 (s, 2H), 5.11 (s, 2H), 6.99–7.05 (m, 8H),
7.44–7.51 ppm (m, 13H); 13C NMR: d = ꢀ5.2, 18.5, 26.1, 29.9, 49.0, 51.1,
61.4, 61.7, 67.0, 67.6, 70.4, 115.3, 115.4, 127.7, 128.0, 128.1, 128.2, 128.8,
133.9, 134.2, 134.4, 137.4, 157.7, 158.1, 158.3, 168.6 ppm.
N,N-Bis(2-(tert-butyldimethylsilyloxy)ethyl)-2-(4’-(2-(4’-hydroxybiphenyl-
4-yloxy)ethoxy)biphenyl-4-yloxy)acetamide (M): Palladium on carbon
(10%, 0.32 g) was added to a hot solution of L (0.29 g, 0.34 mmol) in
EtOAc (10 mL) and shaken (Parr apparatus) at 60 psi H2 for 40 h. The
mixture was filtered hot and the solids were washed twice with CHCl3.
The combined organic phases were evaporated to afford M as a white
[2] B. Hille in Ionic Channels of Excitable Membranes, 3rd ed., Sinauer
Associates, Sunderland, 2001.
[4] S. Das, U. D. Lengweiler, D. Seebach, R. N. Reusch, Proc. Natl.
10552
ꢀ 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2009, 15, 10543 – 10553